Can cannabinoids be used to treat cancer?

When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect. Yet cannabinoids, which have also shown strong activity against human tumor tissue grown in animal models, have undergone minimal testing in patients. Their potential use as antitumor drugs and/or to boost the effectiveness of conventional cancer therapies is examined in an article published in The Journal of Alternative and Complementary Medicine (JACM), a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on JACM website.

In "A Review of the Therapeutic Antitumor Potential of Cannabinoids," coauthors Višnja Bogdanović and Jasminka Mrdjanović, Oncology Institute of Vojvodina (Sremska Kamenica, Serbia), and Ivana Borišev, University of Novi Sad (Serbia) present the results of a detailed survey of the medical and scientific literature focused on the effects of cannabinoids on signaling pathways involved in tumor cell proliferation and death. The researchers review the mechanisms of anticancer activity of cannabinoids, discuss the similarities and differences between exogenous (plant-derived) and endogenous cannabinoids, report on the clinical studies conducted to date to assess the anti-tumor effects of these compounds, and consider the possible adjuvant properties of cannabinoids in cancer treatment.

"Although medical cannabis is well-supported in the literature for symptom reduction from cancer treatment or the disease itself, there are many claims that cannabis can treat cancer itself," says Leslie Mendoza Temple, MD, ABOIM, University of Chicago Pritzker School of Medicine and Medical Director, Integrative Medicine Program. "So far, this is based on only a handful of small human studies, anecdote, or laboratory research. This article nicely summarizes some of the work done in the lab for an understanding of cannabis' potential anti-cancer mechanisms, while pointing to the paucity of human trials." Dr. Temple adds, "Federal rescheduling of cannabis is critical so we can study its effects in humans and determine cannabis' direct or indirect effects on cancer cells."

"The value of the review from Bogdanović, Mrdjanović, and Borišev is describing the evidence landscape that is generating claims for this very political herb," says JACM Editor-in-Chief John Weeks, Seattle, WA. He adds: "The evidence supports freeing researchers to provide us with more answers."

Bogdanović Višnja, Mrdjanović Jasminka, Borišev Ivana.
A Review of the Therapeutic Antitumor Potential of Cannabinoids.
The Journal of Alternative and Complementary Medicine. doi: 10.1089/acm.2017.0016.

Most Popular Now

Roche launches NAVIFY Tumor Board solution to prov…

Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-...

Tagrisso granted breakthrough therapy designation …

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatm...

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

Pfizer reviewing strategic alternatives for Consum…

Pfizer Inc. is reviewing strategic alternatives for its Consumer Healthcare business. A range of options will be considered, including a full or partial separation of the...

FDA accepts Bristol-Myers Squibb's application for…

Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its supplemental Biologics License Ap...

FDA accepts regulatory submission for Lynparza in …

AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has accepted and granted...

Indian government needs to do more to tackle risin…

In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of...

Chemistry provides a new supply of a promising can…

A drug isolated from a marine pest holds promise for treating some of the world's nastiest diseases, and researchers would love to find out just how effective it is - if ...

Social Media in the Pharmaceutical Industry

22 - 23 January 2018, London, UK. Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and ph...

Allergy drug improves function in patients with ch…

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully c...

Three of the most deadly cancers get critical fund…

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the de...

New drug hope for rare bone cancer patients

Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, Unive...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]